• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性帕金森病患者脑脊液中DJ-1水平升高。

Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease.

作者信息

Waragai Masaaki, Wei Jianshe, Fujita Masayo, Nakai Masaaki, Ho Gilbert J, Masliah Eliezer, Akatsu Hiroyasu, Yamada Tatsuo, Hashimoto Makoto

机构信息

Laboratory for Chemistry and Metabolism, Tokyo Metropolitan Institute for Neuroscience, Tokyo 183-8526, Japan.

出版信息

Biochem Biophys Res Commun. 2006 Jul 7;345(3):967-72. doi: 10.1016/j.bbrc.2006.05.011. Epub 2006 May 11.

DOI:10.1016/j.bbrc.2006.05.011
PMID:16707095
Abstract

DJ-1 is an antioxidant protein whose loss of function by gene mutations has been linked to familial Parkinson's disease (PD). The main objective of the present study was to determine if this molecule was also involved in the pathogenesis of sporadic PD. For this purpose, quantitative immunoblot assays were performed to evaluate DJ-1 in cerebrospinal fluids (CSF) collected from sporadic PD patients (n=40) and non-PD controls (n=38). The results showed that the CSF DJ-1 levels in PD were significantly higher than those in non-PD controls. Especially, upregulation of CSF DJ-1 in the early stage of PD (Yahr I-II) were distinct compared to those in the advanced stage of PD (Yahr III-IV) and non-PD controls (p<0.001 by ANOVA with post hoc Bonferroni's test), suggesting a protective role of DJ-1 against oxidative stress during the early stage. Thus, we propose that CSF DJ-1 could be a possible biomarker for early sporadic PD.

摘要

DJ-1是一种抗氧化蛋白,其因基因突变导致的功能丧失与家族性帕金森病(PD)有关。本研究的主要目的是确定该分子是否也参与散发性PD的发病机制。为此,进行了定量免疫印迹分析,以评估从散发性PD患者(n = 40)和非PD对照(n = 38)收集的脑脊液(CSF)中的DJ-1。结果显示,PD患者脑脊液中DJ-1水平显著高于非PD对照。特别是,与PD晚期(Yahr III-IV)和非PD对照相比,PD早期(Yahr I-II)脑脊液中DJ-1的上调明显(方差分析后经Bonferroni检验,p<0.001),表明DJ-1在早期对氧化应激具有保护作用。因此,我们认为脑脊液DJ-1可能是早期散发性PD的一个潜在生物标志物。

相似文献

1
Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease.散发性帕金森病患者脑脊液中DJ-1水平升高。
Biochem Biophys Res Commun. 2006 Jul 7;345(3):967-72. doi: 10.1016/j.bbrc.2006.05.011. Epub 2006 May 11.
2
Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease.血浆DJ-1水平作为散发性帕金森病进展的一种可能标志物。
Neurosci Lett. 2007 Sep 20;425(1):18-22. doi: 10.1016/j.neulet.2007.08.010. Epub 2007 Aug 11.
3
CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls.脑脊液中 DJ-1 和 tau 水平可将 MSA 患者与 PD 患者和对照组区分开来。
Parkinsonism Relat Disord. 2014 Jan;20(1):112-5. doi: 10.1016/j.parkreldis.2013.09.003. Epub 2013 Sep 12.
4
DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease.DJ-1 和α-突触核蛋白在人脑脊液中作为帕金森病的生物标志物。
Brain. 2010 Mar;133(Pt 3):713-26. doi: 10.1093/brain/awq008. Epub 2010 Feb 15.
5
DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function.DJ-1 和 αSYN 在 LRRK2 CSF 中与纹状体多巴胺能功能不相关。
Neurobiol Aging. 2012 Apr;33(4):836.e5-7. doi: 10.1016/j.neurobiolaging.2011.09.015. Epub 2011 Oct 21.
6
α-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson's Disease.α-突触核蛋白和 DJ-1 作为帕金森病潜在的生物体液生物标志物。
Int J Mol Sci. 2010 Oct 29;11(11):4257-66. doi: 10.3390/ijms11114257.
7
Secretion of DJ-1 into the serum of patients with Parkinson's disease.DJ-1在帕金森病患者血清中的分泌。
Neurosci Lett. 2008 Jan 24;431(1):86-9. doi: 10.1016/j.neulet.2007.11.027. Epub 2007 Dec 4.
8
Correlation between DJ-1 levels in the cerebrospinal fluid and the progression of disabilities in multiple sclerosis patients.脑脊液中DJ-1水平与多发性硬化症患者残疾进展之间的相关性。
Mult Scler. 2008 Sep;14(8):1056-60. doi: 10.1177/1352458508093616. Epub 2008 Jul 16.
9
Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.由致病性DJ-1突变和氧化应激介导的DJ-1与帕金蛋白的关联。
Hum Mol Genet. 2005 Jan 1;14(1):71-84. doi: 10.1093/hmg/ddi007. Epub 2004 Nov 3.
10
The influence of preanalytical conditions on the DJ-1 concentration in human cerebrospinal fluid.分析前条件对人脑脊液中DJ-1浓度的影响。
Biomark Med. 2014;8(3):387-94. doi: 10.2217/bmm.13.125.

引用本文的文献

1
Redox modulatory role of DJ-1 in Parkinson's disease.DJ-1在帕金森病中的氧化还原调节作用。
Biogerontology. 2025 Mar 30;26(2):81. doi: 10.1007/s10522-025-10227-w.
2
Neuroprotective role and mechanistic insights of DJ-1 dimerization in Parkinson's disease.DJ-1二聚化在帕金森病中的神经保护作用及机制洞察
Cell Commun Signal. 2025 Mar 10;23(1):129. doi: 10.1186/s12964-025-02136-9.
3
Biofluid Markers and Tissue Biopsies Analyses for the Prodromal and Earliest Phase of Parkinson's Disease.生物流体标志物和组织活检分析在帕金森病的前驱期和早期阶段。
J Parkinsons Dis. 2024;14(s2):S333-S344. doi: 10.3233/JPD-240007.
4
Clinical value of serum DJ-1 in lung adenocarcinoma.血清DJ-1在肺腺癌中的临床价值。
PeerJ. 2024 Jan 29;12:e16845. doi: 10.7717/peerj.16845. eCollection 2024.
5
Post-translational modification and mitochondrial function in Parkinson's disease.帕金森病中的翻译后修饰与线粒体功能
Front Mol Neurosci. 2024 Jan 11;16:1329554. doi: 10.3389/fnmol.2023.1329554. eCollection 2023.
6
Blood biomarker-based classification study for neurodegenerative diseases.基于血液生物标志物的神经退行性疾病分类研究。
Sci Rep. 2023 Oct 11;13(1):17191. doi: 10.1038/s41598-023-43956-4.
7
How should we be using biomarkers in trials of disease modification in Parkinson's disease?我们应该如何在帕金森病疾病修饰治疗的临床试验中使用生物标志物?
Brain. 2023 Dec 1;146(12):4845-4869. doi: 10.1093/brain/awad265.
8
Parkinson's Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy.帕金森病:从遗传学和表观遗传学治疗到基于 microRNA 的策略。
Int J Mol Sci. 2023 May 31;24(11):9547. doi: 10.3390/ijms24119547.
9
Microglia Mediated Neuroinflammation in Parkinson's Disease.小胶质细胞介导的帕金森病神经炎症。
Cells. 2023 Mar 25;12(7):1012. doi: 10.3390/cells12071012.
10
A Sensor-Based Perspective in Early-Stage Parkinson's Disease: Current State and the Need for Machine Learning Processes.基于传感器的早期帕金森病视角:现状与机器学习过程的需求。
Sensors (Basel). 2022 Jan 6;22(2):409. doi: 10.3390/s22020409.